logo-loader
viewCallitas Health Inc

M Pharmaceutical boss looking forward to a great 2017 and 2018

Gary Thompson is at the helm of drug company M Pharmaceutical, which he describes as a "small company with big ideas".
Talking to Proactive, he said that when finished soon with its acquisition of Cincinnati-based 40 J’s, it will have a current revenue stream from about seven different products, which are FDA cleared.
There are also excitingly two products going through FDA process now - a side-effect-free version of the best-selling slimming product orlistat and a female sexual dysfunction (FSD) remedy.
"I'm looking forward to a great 2017 and 2018," said Thompson.

Quick facts: Callitas Health Inc

Price: - CAD

CSE:LILY
Market: CSE
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Callitas Health Inc named herein, including the promotion by the Company of Callitas Health Inc in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

SDCL Energy Efficiency Income Trust on track to achieve target dividend of 5p

SDCL Energy Efficiency Income Trust PLC's (LON:SEIT) got a portfolio of 26 energy efficiency investments located in the UK, continental Europe and North America. Co-founder and CEO Jonathan Maxwell says they're on track to achieve the target dividend of 5p per share for the year to 31 March...

16 hours, 49 minutes ago

2 min read